Policy Briefings

The European Biotech Act, Explained

Multistate Lawsuit Targets CDC Childhood Vaccine Rollback

Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next

FDA and EMA Issue Joint AI Principles for Drug Development

EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For

TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?

J&J Strikes Drug Pricing Deal with Trump Administration

Nine Drugmakers Sign Trump MFN Deals in Single Day, Pledge $150B in US Manufacturing

US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds

Trump Administration Launches Review of Global Drug Pricing Practises

AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal

Trump Exempts Generic Drugs from Pharmaceutical Tariffs, Boosting Indian Pharma Stocks

UK Considers Raising NHS Drug Prices to Avoid US Tariffs

Trump Delays 100% Pharma Tariffs to Negotiate Pricing Deals

TrumpRx: Pfizer Signs First Deal for US Drug Platform

Trump’s 100% Pharma Tariffs to United States from October 1: How the industry is responding

Trump Administration Draws Autism-Acetaminophen Link Despite Scientific Skepticism

RFK Jr’s Vaccine Panel Expected to Delay Newborn Hepatitis B Shots Until Age 4

US-EU Trade Deal Caps Pharmaceutical Tariffs at 15%, Averting Higher Levies

FUJIFILM Biotechnologies Wins Most Innovative CDMO Award at 2026 CDMO Leadership Awards

Lifecore Biomedical Signs Two CDMO Agreements with Existing U.S. Customer

Samsung Biologics Wins Sustainability Leadership Award at 2026 CDMO Leadership Awards

Olon Unveils 2026 Global Expansion Plan Across US, India, Italy, and France

BSP Announces €700 Million Expansion Plan for 2026–2030 at DCAT Forum

Experic Partners with Flurry Powders to Advance Spray-Dried Drug Development

LOTTE Biologics Wins Best New or Relaunched CDMO at 2026 CDMO Leadership Awards

Piramal Pharma Solutions Installs Korsch X3 Tablet Press at UK CDMO Site

Aragen Life Sciences Signs MoU with Thermo Fisher to Advance Biologics Manufacturing

SK pharmteco Partners with Prozomix to Access 6,000 Biocatalysts for API Manufacturing

Applied StemCell and Cellipont Bioservices Partner to Advance iPSC Cell Therapy Manufacturing

Rentschler Biopharma Celebrates Milford Site Growth Following U.S. Expansion

AmbioPharm Expands South Carolina Facility with 68,000 Sq Ft Peptide Capacity

Wilmington PharmaTech Announces $50M Expansion to Double API Capacity

Cambrex Advances $120M U.S. API Expansion with Engineering Milestone

Lifecore Biomedical Signs New CDMO Agreement for Market-Approved Aesthetics Product

Kindeva Marks 70 Years Since pMDI Invention as Alumni Enter National Inventors Hall of Fame

Porton Pharma Solutions Forms Strategic Partnership With Jianxiang for Peptide CDMO Services

European CDMO Landscape 2025: Download the latest edition